Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of Outcomes of Everolimus-Eluting Stent (XIENCE V) Implantation for Unprotected Left Main Coronary Artery Stenosis: Multicenter Trial

NCT01348022 is registered in ClinicalTrials.gov with Seung-Jung Park as lead sponsor.

NCT NCT01348022
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01348022 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of Outcomes of Everolimus-Eluting Stent (XIENCE V) Implantation for Unprotected Left Main Coronary Artery Stenosis: Multicenter Trial
Lead sponsor
Seung-Jung Park
Phase
Observational
Overall status
Completed
Start date
August 31, 2009
Completion date
September 30, 2015
Enrollment
397 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease